Literature DB >> 9135524

Carcinoma of the ampulla of Vater: prognostic factors after curative surgery: a series of 45 cases.

A Dorandeu1, J L Raoul, F Siriser, N Leclercq-Rioux, M Gosselin, E D Martin, M P Ramée, B Launois.   

Abstract

BACKGROUND: Some adjuvant or neoadjuvant therapy could be important for patients operated on for tumours of the ampulla of Vater, especially for those having a higher risk of recurrence. AIM: To evaluate prognostic factors after curative surgery based on a series of 45 cases of malignant tumours of the Oddi sphincter. PATIENTS: From 1970 to 1992, a curative resection was performed in 45 patients (age 62.8 (SD 10.1) years) with adenocarcinoma of the ampulla. Surgical procedures included pancreatoduodenectomy (n = 42) and resection of the ampulla (n = 3). Actuarial survival was 44 (SD 9)% at five years.
METHODS: Various prognostic variables were studied: clinical manifestations, macroscopic aspect, differentiation, noninvasive adenomatous component, mucin histochemistry, immunohistochemistry (CEA, CA19.9, p53, Ki67), and accepted classifications (Blumgart and Kennedy, Martin, Yamaguchi and Enjoji, Talbot et al, pTNM).
RESULTS: Variables with prognostic power, in order of importance were: Classification of Talbot et al; CA19.9; pTNM; sialomucins; classification of Yamaguchi and Ejoji; Martin classification; sulphomucins; non-invasive adenomatous component (positive > negative); jaundice; tumour localisation.
CONCLUSIONS: This series confirmed the prognostic power of former classifications and showed the prognostic power of other variables (mucin, non-invasive adenomatous component, CA19.9).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135524      PMCID: PMC1027085          DOI: 10.1136/gut.40.3.350

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  The histopathology and staging of carcinoma of the ampulla of Vater.

Authors:  I C Talbot; J P Neoptolemos; D E Shaw; D Carr-Locke
Journal:  Histopathology       Date:  1988-02       Impact factor: 5.087

2.  Pancreatoduodenal carcinoma: a clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA19-9.

Authors:  K Yamaguchi; M Enjoji; M Tsuneyoshi
Journal:  J Surg Oncol       Date:  1991-07       Impact factor: 3.454

3.  Carcinoma of the pancreas and papilla of Vater: presenting symptoms, signs, and diagnosis related to stage and tumour site. A prospective multicentre trial in 472 patients. Norwegian Pancreatic Cancer Trial.

Authors:  K E Bakkevold; B Arnesjø; B Kambestad
Journal:  Scand J Gastroenterol       Date:  1992-04       Impact factor: 2.423

4.  Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study.

Authors:  T A Splinter; H Obertop; T C Kok; J Jeekel
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  Significance of tumor spread in adenocarcinoma of the ampulla of Vater.

Authors:  R Delcore; C S Connor; J H Thomas; S R Friesen; A S Hermreck
Journal:  Am J Surg       Date:  1989-12       Impact factor: 2.565

6.  Endoscopic biopsy has limited accuracy in diagnosis of ampullary tumors.

Authors:  K Yamaguchi; M Enjoji; K Kitamura
Journal:  Gastrointest Endosc       Date:  1990 Nov-Dec       Impact factor: 9.427

7.  Pathological factors influencing survival of carcinoma of the ampulla of Vater.

Authors:  K Mori; S Ikei; T Yamane; Y Yamaguchi; T Katsumori; Y Shibata; T Arai
Journal:  Eur J Surg Oncol       Date:  1990-06       Impact factor: 4.424

8.  Adenoma of the ampulla of Vater: putative precancerous lesion.

Authors:  K Yamaguchi; M Enjoji
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

9.  Influence of site of origin and mucin production on survival in ampullary carcinoma.

Authors:  P J Dawson; M M Connolly
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

10.  Radical resection for carcinoma of the ampulla of Vater.

Authors:  J R Monson; J H Donohue; G P McEntee; D C McIlrath; J A van Heerden; R G Shorter; D M Nagorney; D M Ilstrup
Journal:  Arch Surg       Date:  1991-03
View more
  11 in total

1.  Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.

Authors:  Xing-Lei Qin; Zhuo-Ren Wang; Jing-Sen Shi; Min Lu; Lin Wang; Quan-Ru He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.

Authors:  Y M Shyr; C H Su; L H Wu; A F Li; J H Chiu; C W Wu; W Y Lui
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

3.  Increased levels of sperm protein 17 mRNA and circulating antibodies in periampullary carcinoma patients.

Authors:  Shivam Singh; Anoop Saraya; Rinu Sharma
Journal:  Int J Clin Oncol       Date:  2014-10-29       Impact factor: 3.402

4.  Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis.

Authors:  A Scarpa; C Di Pace; G Talamini; M Falconi; N R Lemoine; C Iacono; A Achille; A Baron; G Zamboni
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

5.  Jaundice at presentation heralds advanced disease and poor prognosis in patients with ampullary carcinoma.

Authors:  Naoyuki Yokoyama; Yoshio Shirai; Toshifumi Wakai; Shigenori Nagakura; Kohei Akazawa; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2005-04       Impact factor: 3.352

6.  Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.

Authors:  D Santini; G Tonini; F M Vecchio; D Borzomati; B Vincenzi; S Valeri; A Antinori; F Castri; R Coppola; P Magistrelli; G Nuzzo; A Picciocchi
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

7.  Markers of bile duct tumors.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Alessandra Rando; Mario Uccello; Francesco Basile; Antonio Biondi; Santo Carnazzo; Innocenza Alessandria; Clorinda Mazzarino
Journal:  World J Gastrointest Oncol       Date:  2011-04-15

8.  Usefulness of follow-up after pancreatoduodenectomy for carcinoma of the ampulla of Vater.

Authors:  Laurence Chiche; Barbara Alkofer; Jean-Jacques Parienti; Vincent Rouleau; Ephrem Salamé; Guy Samama; Philippe Segol
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

9.  Adenocarcinoma of the ampulla of Vater: predictors of survival and recurrence after curative radical resection.

Authors:  Kang Jae Kim; Dong Wook Choi; Woo Seok Kim; Min Jung Kim; Sun Choon Song; Jin Seok Heo; Seong Ho Choi
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-08-31

10.  The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma.

Authors:  Yuki Sato; Daichi Fujimoto; Keiichiro Uehara; Ryoko Shimizu; Jiro Ito; Mariko Kogo; Shunsuke Teraoka; Ryoji Kato; Kazuma Nagata; Atsushi Nakagawa; Kojiro Otsuka; Hiroshi Hamakawa; Yutaka Takahashi; Yukihiro Imai; Keisuke Tomii
Journal:  BMC Cancer       Date:  2016-11-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.